Home/Filings/4/0001209191-20-051046
4//SEC Filing

Sukhtian Faisal Ghiath 4

Accession 0001209191-20-051046

CIK 0001649989other

Filed

Sep 16, 8:00 PM ET

Accepted

Sep 17, 7:18 PM ET

Size

5.1 KB

Accession

0001209191-20-051046

Insider Transaction Report

Form 4
Period: 2020-09-17
Transactions
  • Purchase

    Common Stock

    2020-09-17$0.67/sh+10,000$6,73110,000 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6691 to $0.6789, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.

Issuer

Outlook Therapeutics, Inc.

CIK 0001649989

Entity typeother

Related Parties

1
  • filerCIK 0001716033

Filing Metadata

Form type
4
Filed
Sep 16, 8:00 PM ET
Accepted
Sep 17, 7:18 PM ET
Size
5.1 KB